Terms: = Lymphoma AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG AND Prognosis
56 results:
1. [Clinicopathological features of intravascular large B-cell lymphoma and collision tumors of five cases].
Liu J; Liu GZ; Xia L; Wang HY; Zhang XF; Liu H
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):22-28. PubMed ID: 38178742
[No Abstract] [Full Text] [Related]
2. High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia.
Oikonomou A; Valsecchi L; Quadri M; Watrin T; Scharov K; Procopio S; Tu JW; Vogt M; Savino AM; Silvestri D; Valsecchi MG; Biondi A; Borkhardt A; Bhatia S; Cazzaniga G; Fazio G; Bardini M; Palmi C
Biochem Pharmacol; 2023 Nov; 217():115809. PubMed ID: 37717691
[TBL] [Abstract] [Full Text] [Related]
3. Cancer-specific apoptosis induction in canine lymphoma cell lines by the endocytosis inhibitor dynasore.
Suemura M; Miyata H; Kawamura R; Takahashi S; Igase M; Mizuno T; Ohama T; Shibutani S; Iwata H
J Vet Med Sci; 2023 Aug; 85(8):820-827. PubMed ID: 37407446
[TBL] [Abstract] [Full Text] [Related]
4. ALK-positive Large B-Cell lymphoma With Multiple Epithelial Antigen Expression and PABPC1::ALK Fusion : A Novel Molecular Alteration.
Fu JJ; Seth A; Ali N; Chandar A; Bains A
Am J Surg Pathol; 2023 Aug; 47(8):950-954. PubMed ID: 37326123
[TBL] [Abstract] [Full Text] [Related]
5. Cost‑Effectiveness of Lorlatinib in First-Line Treatment of Adult Patients with Anaplastic lymphoma Kinase (ALK)‑Positive Non‑Small‑Cell Lung Cancer in Sweden.
Naik J; Beavers N; Nilsson FOL; Iadeluca L; Lowry C
Appl Health Econ Health Policy; 2023 Jul; 21(4):661-672. PubMed ID: 37173513
[TBL] [Abstract] [Full Text] [Related]
6.
Qiu L; Tang G; Li S; Vega F; Lin P; Wang SA; Wang W; Iyer SP; Malpica L; Miranda RN; Konoplev S; Tang Z; Fang H; Medeiros LJ; Xu J
Haematologica; 2023 Jun; 108(6):1604-1615. PubMed ID: 36453104
[TBL] [Abstract] [Full Text] [Related]
7. [Nodular lymphocyte predominant Hodgkin lymphoma (paragranuloma of Poppema) in children: Case report, review of the literature and treatment].
Wilgenhof K; Théate I; Devalck C; Forsyth R; Dehou MF
Ann Pathol; 2023 Jan; 43(1):39-44. PubMed ID: 36008237
[TBL] [Abstract] [Full Text] [Related]
8. What to use to treat AML: the role of emerging therapies.
Thol F
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):16-23. PubMed ID: 34889359
[TBL] [Abstract] [Full Text] [Related]
9. Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK + LBCL): a systematic review of clinicopathological features and management.
Castillo JJ; Beltran BE; Malpica L; Marques-Piubelli ML; Miranda RN
Leuk Lymphoma; 2021 Dec; 62(12):2845-2853. PubMed ID: 34151703
[TBL] [Abstract] [Full Text] [Related]
10. Diagnostic Challenge of Sarcomatoid Variant of ALK-Positive Anaplastic Large Cell lymphoma: Case Report and Updated Systematic Literature Review.
Song F; Yu S; Jia M; Gao H; Sun PL
Int J Surg Pathol; 2021 Sep; 29(6):658-666. PubMed ID: 33427000
[TBL] [Abstract] [Full Text] [Related]
11. [Isolated plasmablastic lymphoma of nasal mucosa in an immunocompetent patient achieving complete remission after multimodal treatment: about an African patient and literature review].
Tissir R; Rais H; Tazi I
Pan Afr Med J; 2020; 37():22. PubMed ID: 33062124
[TBL] [Abstract] [Full Text] [Related]
12. Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the ema for Minimal Residual Disease.
Ali S; Moreau A; Melchiorri D; Camarero J; Josephson F; Olimpier O; Bergh J; Karres D; Tzogani K; Gisselbrecht C; Pignatti F
Oncologist; 2020 Apr; 25(4):e709-e715. PubMed ID: 32297447
[TBL] [Abstract] [Full Text] [Related]
13. [Un- and dedifferentiated endometrial carcinoma : A rare entity with a wide range of differential diagnosis].
Höhn AK; Brambs CE; Opitz S; Erber R; Hartmann A; Horn LC
Pathologe; 2019 Nov; 40(6):609-618. PubMed ID: 31578630
[TBL] [Abstract] [Full Text] [Related]
14. Expression of mucins (muc1, MUC2, MUC5AC and MUC6) in ALK-positive lung cancer: Comparison with EGFR-mutated lung cancer.
Lee HK; Kwon MJ; Seo J; Kim JW; Hong M; Park HR; Min SK; Choe JY; Ra YJ; Jang SH; Hwang YI; Kim HY; Min KW
Pathol Res Pract; 2019 Mar; 215(3):459-465. PubMed ID: 30580903
[TBL] [Abstract] [Full Text] [Related]
15. Glycan-directed CAR-T cells.
Steentoft C; Migliorini D; King TR; Mandel U; June CH; Posey AD
Glycobiology; 2018 Sep; 28(9):656-669. PubMed ID: 29370379
[TBL] [Abstract] [Full Text] [Related]
16. Cutaneous T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease.
Argnani L; Broccoli A; Zinzani PL
Cancer Treat Rev; 2017 Dec; 61():61-69. PubMed ID: 29102679
[TBL] [Abstract] [Full Text] [Related]
17. The masquerading presentation of a systemic anaplastic large cell lymphoma, ALK positive: a case report and review of the literature.
Al-Ahmad S; Maertens V; Libeer C; Schelfhout V; Vanhoenacker F; Boeckx N; Vandevenne M
Acta Clin Belg; 2017 Dec; 72(6):454-460. PubMed ID: 28441913
[TBL] [Abstract] [Full Text] [Related]
18. Pathologic character and diagnosis of female primary genital system diffuse large B cell lymphoma.
Cheng H; Tang X; Cheng J; Zhang B; Zhang YL; Wang WQ; Teng P
Eur Rev Med Pharmacol Sci; 2017 Apr; 21(7):1471-1476. PubMed ID: 28429361
[TBL] [Abstract] [Full Text] [Related]
19. Fine-needle aspiration cytology yield as a basis for morphological, molecular, and cytogenetic diagnosis in alk-positive anaplastic large cell lymphoma with atypical clinical presentation.
Bogdanic M; Ostojic Kolonic S; Kaic G; Kardum Paro MM; Lasan Trcic R; Kardum-Skelin I
Diagn Cytopathol; 2017 Jan; 45(1):51-54. PubMed ID: 27468968
[TBL] [Abstract] [Full Text] [Related]
20. Epithelioid inflammatory myofibroblastic sarcoma with recurrence after extensive resection: significant clinicopathologic characteristics of a rare aggressive soft tissue neoplasm.
Zhou J; Jiang G; Zhang D; Zhang L; Xu J; Li S; Li W; Ma Y; Zhao A; Zhao Z
Int J Clin Exp Pathol; 2015; 8(5):5803-7. PubMed ID: 26191301
[TBL] [Abstract] [Full Text] [Related]
[Next]
